相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
Ji Luo et al.
CELL (2009)
Small Molecule Targeting the Hec1/Nek2 Mitotic Pathway Suppresses Tumor Cell Growth in Culture and in Animal
Guikai Wu et al.
CANCER RESEARCH (2008)
The consequences of Rad51 overexpression for normal and tumor cells
Hannah L. Klein
DNA REPAIR (2008)
A forward chemical genetic screen reveals an inhibitor of the Mre11-Rad50-Nbs1 complex
Aude Dupre et al.
NATURE CHEMICAL BIOLOGY (2008)
Prevention of Brca1-mediated mammary tumorigenesis in mice by a progesterone antagonist
Aleksandra Jovanovic Poole et al.
SCIENCE (2006)
Relative contribution of homologous recombination and non-homologous end-joining to DNA double-strand break repair after oxidative stress in Saccharomyces cerevisiae
Lucia Letauayova et al.
DNA REPAIR (2006)
Rad51 siRNA delivered by HVJ envelope vector enhances the anti-cancer effect of cisplatin
M Ito et al.
JOURNAL OF GENE MEDICINE (2005)
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
HE Bryant et al.
NATURE (2005)
The development of imatinib as a therapeutic agent for chronic myeloid leukemia
M Deininger et al.
BLOOD (2005)
Targeting of Rad51-dependent homologous recombination:: implications for the radiation sensitivity of human lung cancer cell lines
A Sak et al.
BRITISH JOURNAL OF CANCER (2005)
A hot spot for RAD51C interactions revealed by a peptide that sensitizes cells to cisplatin
PP Connell et al.
CANCER RESEARCH (2004)
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
LT Vassilev et al.
SCIENCE (2004)
Crystal structure of a Rad51 filament
AB Conway et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2004)
Overriding imatinib resistance with a novel ABL kinase inhibitor
NP Shah et al.
SCIENCE (2004)
Mechanisms and implications of imatinib resistance mutations in BCR-ABL
V Nardi et al.
CURRENT OPINION IN HEMATOLOGY (2004)
Dynamic control of Rad51 recombinase by self-association and interaction with BRCA2
DS Yu et al.
MOLECULAR CELL (2003)
Full-length archaeal Rad51 structure and mutants: mechanisms for RAD51 assembly and control by BRCA2
DS Shin et al.
EMBO JOURNAL (2003)
Insights into DNA recombination from the structure of a RAD51-BRCA2 complex
L Pellegrini et al.
NATURE (2002)
Imatinib mesylate (STI571) inhibits growth of primitive malignant progenitors in chronic myelogenous leukemia through reversal of abnormally increased proliferation
MS Holtz et al.
BLOOD (2002)
Genomic instability in mice lacking histone H2AX
A Celeste et al.
SCIENCE (2002)
Oncogenic tyrosine kinases and the DNA-damage response
T Skorski
NATURE REVIEWS CANCER (2002)
BCR/ABL regulates mammalian RecA homologs, resulting in drug resistance
A Slupianek et al.
MOLECULAR CELL (2001)
Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification
ME Gorre et al.
SCIENCE (2001)
Role of BRCA2 in control of the RAD51 recombination and DNA repair protein
AA Davies et al.
MOLECULAR CELL (2001)
分享论文
